an overview of a practice-changing trial with mfolfirinox in pancreatic cancer
Published 6 years ago • 239 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
1:14
improving outcomes in pancreatic cancer with perioperative mfolfirinox
-
1:57
dr. conroy discusses adjuvant mfolfirinox in pancreatic cancer
-
3:59
adjuvant mfolfirinox shows benefits over gemcitabine in pancreatic cancer | thierry conroy
-
4:04
alliance trials: combination of modified folfirinox and radiotherapy for pancreatic cancer
-
4:56
advancing outcomes in pancreatic cancer
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
3:56
polo trial in pancreatic cancer
-
1:30
dr. philip on the impact of the prodige 24/cctg pa.6 study in pancreatic cancer
-
1:43:59
personal insights on current practices and evolving standards of care in pancreatic cancer
-
56:52
for the pancreatic cancer patient: the abc’s of finding a clinical trial with dr. anand
-
0:53
rationale for locally aggressive treatment of pancreatic cancer
-
5:40
pancreatic cancer survival extended by over a year with chemotherapy regimen
-
6:10
practical advice: pancreas cancer adjuvant therapy
-
0:53
second-line treatment strategies for pancreatic cancer
-
1:48
evaluating the effects of the opera trial in clinical practice
-
4:20
advances in the management of pancreatic cancer - line 2 stop 3 adjuvant therpay practice changing
-
1:46
prodige 24- adjuvant #gemcitabine versus modified folfirinox in resected #pancreaticcancer
-
1:18
expert discusses practice-changing data from katherine trial in breast cancer
-
49:25
pancreatic cancer clinical trials: how research brings new treatments to patients